Maes M, Jirakran K, Vasupanrajit A, Zhou B, Tunvirachaisakul C, Stoyanov D, Almulla A.
Journal Article 2024; 45(6): 393-408 PubMed PMID: 39732467 CitationBACKGROUND: Severe or recurring major depression is associated with increased adverse childhood experiences (ACEs), heightened atherogenic.....
Maes M, Jirakran K, Vasupanrajit A, Zhou B, Tunvirachaisakul C, Stoyanov D, Almulla A. Are abnormalities in lipid metabolism, together with adverse childhood experiences, the silent causes of immune-linked neurotoxicity in major depression? Neuro Endocrinol Lett. 2024 Dec; 45(6): 393-408
Maes M, Almulla A, Vojdani E, Dzhambazova E, Stoyanov D, Zhang Y, Vojdani A.
Journal Article 2025; 46(1): 15-26 PubMed PMID: 40319455 CitationBACKGROUND: Relapsing-remitting multiple sclerosis (RRMS) is defined by elevated IgG/IgA/IgM responses targeting Epstein-Barr Virus (EBV) .....
Maes M, Almulla A, Vojdani E, Dzhambazova E, Stoyanov D, Zhang Y, Vojdani A. Chronic fatigue syndrome, depression, and anxiety symptoms due to relapsing-remitting multiple sclerosis are associated with reactivation of Epstein-Barr virus and Human Herpesvirus 6. Neuro Endocrinol Lett. 2025 Apr; 46(1): 15-26
Maes M, Jirakran K, Semeão L, Michelin A, Matsumoto A, Brinholi F, Barbosa D, Tivirachaisakul C, Almulla A, Stoyanov D, Zhang Y.
Journal Article 2025; 46(2): 115-125 PubMed PMID: 40929711 Keywords: Humans, Aryldialkylphosphatase:metabolism, Depressive Disorder, Major:metabolism, Female, Male, Middle Aged, Adult, Cytokines:metabolism, Atherosclerosis:metabolism, Cholesterol:metabolism, Metabolic Syndrome:metabolism, Outpatients, Oxidative Stress:physiology, Advanced Oxidation Protein Products:metabolism, Phosphatidylcholine-Sterol O-Acyltransferase:metabolism, Oxidation-Reduction,. CitationBACKGROUND: Major depressive disorder (MDD) is associated with neuro-immune - metabolic - oxidative (NIMETOX) pathways. AIMS: .....
Maes M, Jirakran K, Semeão L, Michelin A, Matsumoto A, Brinholi F, Barbosa D, Tivirachaisakul C, Almulla A, Stoyanov D, Zhang Y. Key factors underpinning neuroimmune-metabolic-oxidative (NIMETOX) major depression in outpatients: paraoxonase 1 activity, reverse cholesterol transport, increased atherogenicity, protein oxidation, and differently expressed cytokine networks. Neuro Endocrinol Lett. 2025 Sep; 46(2): 115-125